Literature DB >> 3976704

Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities.

C E Viquerat, P Daly, K Swedberg, C Evers, D Curran, W W Parmley, K Chatterjee.   

Abstract

Plasma free epinephrine, norepinephrine, and dopamine concentrations were determined in 48, 63, and 45 patients, respectively, with overt congestive heart failure, and compared with those in 26 patients with stable angina but without heart failure. Systemic hemodynamic values were determined to assess the severity of heart failure. Arterial epinephrine levels were not different between patients with heart failure (73 +/- 92 pg/ml) and patients without heart failure (55 +/- 73 pg/ml). In patients with congestive heart failure, norepinephrine (665 +/- 510 pg/ml, mean +/- SD) and dopamine (407 +/- 405 pg/ml) levels were significantly higher than in patients with stable angina without heart failure (norepinephrine 184 +/- 136 pg/ml, p less than 0.001, and dopamine 197 +/- 259 pg/ml, p less than 0.02). However, in patients with congestive heart failure, the plasma norepinephrine levels did not correlate with cardiac index (r = 0.21, p = NS), pulmonary capillary wedge pressure (r = 0.11, p = NS), mean arterial pressure (r = 0.11, p = NS), or systemic vascular resistance (r = 0.18, p = NS). Similarly, there was no correlation between dopamine levels and the hemodynamic abnormalities in patients with congestive heart failure. These findings suggest that although endogenous norepinephrine and dopamine levels are frequently elevated in patients with heart failure, reflecting enhanced sympathetic activity, catecholamine levels do not reflect the severity of heart failure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3976704     DOI: 10.1016/0002-9343(85)90338-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

1.  Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.

Authors:  R Kozlik; H H Kramer; H Wicht; A Krian; J Ostermeyer; D Reinhardt
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

Review 2.  [Effects of dopamine on cellular and humoral immune responses in septic patients].

Authors:  G Beck; C Hanusch; P Brinkkoetter; N Rafat; J Schulte; K van Ackern; B Yard
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

3.  Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up.

Authors:  P Otasevic; Z B Popovic; J D Vasiljevic; L Pratali; A Vlahovic-Stipac; S D Boskovic; N Tasic; A N Neskovic
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

4.  Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.

Authors:  S Gasic; G Heinz; C Kleinbloesem; A Korn
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  The acute effects of a single dopamine infusion in elderly patients with congestive cardiac failure.

Authors:  T Robinson; S Gariballa; G Fancourt; J Potter; M Castleden
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

Review 6.  Drug therapy in chronic heart failure.

Authors:  D B McKenzie; A J Cowley
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

7.  Intravenous fenoldopam infusion in severe heart failure.

Authors:  J J Patel; A S Mitha; P Sareli; J B de Vaal
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

8.  Influence of cardiovascular diseases upon the results of the cardiovascular reflex tests in diabetic and nondiabetic subjects.

Authors:  K Krönert; K Holder; G Kuschmierz; B Mayer; W Renn; D Luft; M Eggstein
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar

9.  Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients.

Authors:  Thomas Schilling; Matthias Gründling; Christof M Strang; Klaus-Uwe Möritz; Werner Siegmund; Thomas Hachenberg
Journal:  Intensive Care Med       Date:  2004-05-11       Impact factor: 17.440

10.  Neuroendocrine activity in untreated heart failure.

Authors:  J Remes; I Tikkanen; F Fyhrquist; K Pyörälä
Journal:  Br Heart J       Date:  1991-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.